Combined Inhibitions of Glycolysis and AKT/autophagy Can Overcome Resistance to EGFR-targeted Therapy of Lung Cancer

Efficacy of EGFR-targeted tyrosine kinase inhibitors (TKIs), such as erlotinib, to treat human non-small cell lung cancers (NSCLCs) with activating mutations in EGFR is not persistent due to drug resistance. Reprogramming in energy (especially glucose) metabolism plays an important role in developme...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Cancer
Main Authors: Ye, Mingtong, Wang, Sufan, Wan, Ting, Jiang, Rui, Qiu, Yun, Pei, Lei, Pang, Nengzhi, Huang, Yuanling, Huang, Yufeng, Zhang, Zhenfeng, Yang, Lili
Formato: Artigo
Idioma:Inglês
Publicado em: Ivyspring International Publisher 2017
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5688931/
https://ncbi.nlm.nih.gov/pubmed/29151965
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/jca.21035
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados